Literature DB >> 6739797

Surgical and radiological decompression in malignant biliary obstruction: a retrospective study using multivariate risk factor analysis.

D Bonnel, J T Ferrucci, P R Mueller, F Lacaine, H F Peterson.   

Abstract

We performed a retrospective computer-aided statistical study of 228 patients who received treatment for malignant biliary obstruction to compare survival rates after surgical or radiological biliary decompression. To adjust for the selection bias produced by the clinical choice of surgical vs. catheter drainage, we examined differences in survival rates after controlling for various clinical and laboratory factors, which are predictive of short and long-term survival. These factors were selected by multivariate analysis. Short-term survival was significantly correlated with preoperative metabolic status as reflected in serum albumin, and blood urea nitrogen (BUN) levels. Elevated serum bilirubin values had no additional negative effect on survival. Long-term survival was influenced mainly by the extent of the primary cancer and the preoperative presence of leukocytosis. Although there was a difference in the raw data for hospital mortality between patients who underwent surgical drainage (11%) and those who underwent radiological drainage (30%), we found no real effect produced by the form of therapy after controlling for prognosis variables, i.e., eliminating selection bias. We propose a simple statistical model to predict short-term hospital survival. The application of objective risk factor analysis according to accepted statistical methods should permit the assessment of new radiologic therapeutic techniques with greater clinical validity.

Entities:  

Mesh:

Year:  1984        PMID: 6739797     DOI: 10.1148/radiology.152.2.6739797

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  8 in total

1.  Combined percutaneous-endoscopic stenting of malignant biliary obstruction: results from 106 consecutive procedures and identification of factors associated with adverse outcome.

Authors:  C P Neal; S C Thomasset; D Bools; C D Sutton; G Garcea; C D Mann; Y Rees; C Newland; R J Robinson; A R Dennison; D P Berry
Journal:  Surg Endosc       Date:  2009-06-30       Impact factor: 4.584

2.  The role of preoperative biliary decompression in the treatment of bile duct cancer.

Authors:  J Yanagisawa; H Ichimiya; N Kuwano; F Nakayama
Journal:  World J Surg       Date:  1988-02       Impact factor: 3.352

3.  Percutaneous transhepatic biliary drainage: experience with 311 procedures.

Authors:  R W Günther; H Schild; M Thelen
Journal:  Cardiovasc Intervent Radiol       Date:  1988-04       Impact factor: 2.740

4.  Does preoperative percutaneous biliary drainage reduce operative risk or increase hospital cost?

Authors:  H A Pitt; A S Gomes; J F Lois; L L Mann; L S Deutsch; W P Longmire
Journal:  Ann Surg       Date:  1985-05       Impact factor: 12.969

5.  Clinical utility of 3D magnetic resonance elastography in patients with biliary obstruction.

Authors:  Yujia Ma; Guoxin Wang; Feng Gao; Bing Ma; Qike Song; Shiling Zhong; Yuanyuan Liu; Yang Hong
Journal:  Eur Radiol       Date:  2021-11-17       Impact factor: 7.034

6.  Management of malignant hilar biliary obstruction by endoscopy. Results and prognostic factors.

Authors:  M Ducreux; C Liguory; J F Lefebvre; O Ink; A Choury; J Fritsch; D Bonnel; S Derhy; J P Etienne
Journal:  Dig Dis Sci       Date:  1992-05       Impact factor: 3.199

7.  Cholangiocarcinoma. Role of percutaneous transhepatic cholangiography in determination of resectability.

Authors:  R B Lynn; J A Wilson; K J Cho
Journal:  Dig Dis Sci       Date:  1988-05       Impact factor: 3.199

8.  Thermodynamic interference with bile acid demicelleization reduces systemic entry and injury during cholestasis.

Authors:  Cristiane de Oliveira; Biswajit Khatua; Bara El-Kurdi; Krutika Patel; Vivek Mishra; Sarah Navina; Bradley J Grim; Srishti Gupta; Marek Belohlavek; Brian Cherry; Jeffery Yarger; Matthew D Green; Vijay P Singh
Journal:  Sci Rep       Date:  2020-05-21       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.